Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
UBS
Farmers Insurance
Cantor Fitzgerald
Covington
US Department of Justice
Queensland Health
Deloitte

Generated: April 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,097,653

« Back to Dashboard

Summary for Patent: 8,097,653
Title:Dosage unit comprising a prostaglandin analog for treating constipation
Abstract: A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
Inventor(s): Ueno; Ryuji (Montgomery, MD), Patchen; Myra L. (Fairfax, VA)
Assignee: Sucampo AG (Zug, CH)
Application Number:10/293,516
Patent Claims: 1. A method for relieving constipation in a human patient in need of relief of constipation that comprises administering to the patient a dosage unit comprising (i) 24 .mu.g+/-10% of a PG analog represented by Formula (I) and/or its tautomer and (ii) a pharmaceutically suitable excipient: ##STR00013## where A.sub.1 and A.sub.2 are fluorine atoms and B is --COOH, including its pharmaceutically acceptable salts, esters or amides, to thereby relieve constipation in the patient, wherein said dosage unit is administered enough times per day so that the total daily dose of the PG analog is in the range of about 48-72 .mu.g.

2. The method of claim 1, wherein said PG analog is a monocyclic tautomer of formula (I).

3. The method of claim 1, wherein said pharmaceutically suitable excipient is orally acceptable.

4. The method of claim 1, wherein said pharmaceutically suitable excipient is a medium chain fatty acid.

5. The method of claim 1, wherein said dosage unit is administered enough times per day so that the total daily dose of the PG analog is about 48 .mu.g.

6. The method of claim 1, wherein the amount of the PG analog in the dosage unit is 24 .mu.g.

7. The method of claim 1, wherein B is --COOH.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
AstraZeneca
US Department of Justice
Harvard Business School
US Army
Fuji
Accenture
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.